Viewing data from:

PREDNISONE

ANDA

PREDNISONE | A088703 | HIKMA PHARMACEUTICALS USA INC

1 strength0 unique patents0 unique exclusivities

Medicare Part B Spending

CMS physician-administered drug spending for PrednIsone (2023)

Total Spending

$639K

Total Claims

348,554

Beneficiaries

46,521

ASP Price

—

HCPCS: J7512 — Prednisone, immediate release or delayed release, oral, 1 mg

Source: CMS Medicare Part B Spending by Drug (2023). Shows physician-administered drug costs.

API Supply Chain9 active DMFs5 inactive

6 active API suppliers hold Drug Master Files for this ingredient.

EUROAPI FRANCEPREDNISONE

DMF 28741977

TIANJIN TIANYAO PHARMACEUTICALS CO LTDPREDNISONE USP

DMF 112891994

CURIA SPAIN SAUPREDNISONE ANHYDROUS USP

DMF 131731998

TIANJIN TIANYAO PHARMACEUTICALS CO LTDPREDNISONE ACETATE USP

DMF 139501999

HIKMA PHARMACEUTICALSPREDNISONE ANHYDROUS USP

DMF 160002002

HENAN LIHUA PHARMACEUTICAL CO LTDPREDNISONE

DMF 247492011

HENAN LIHUA PHARMACEUTICAL CO LTDPREDNISONE ACETATE

DMF 316402017

SHANDONG XINHUA PHARMACEUTICAL CO LTDPREDNISONE ACETATE

DMF 344792020

SHANDONG XINHUA PHARMACEUTICAL CO LTDPREDNISONE

DMF 354612020

SYNTEX LABORATORIES INC SUB SYNTEX CORPInactivePREDNISONE(CRUDE AND CRYSTALLINE)

DMF 2411957

ROUSSEL CORPInactivePREDNISONE

DMF 2601957

PHARMACIA AND UPJOHN CO WHOLLY OWNED SUB PFIZER INCInactivePREDNISONE MICRONIZED, STERILIZED AND ACETATE

DMF 14121969

DIOSYNTH BVInactivePREDNISONE MICRO

DMF 39561980

UPJOHN COInactivePREDNISONE ACETATE, MICRO & NON-MICRO

DMF 54921984

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 5MG/5ML

RLD

0 patents0 exclusivities▴

SOLUTION;ORAL | Approved: Nov 8, 1984

No patent or exclusivity listings for this strength.